HOME >> BIOLOGY >> NEWS
Campbell to receive American Society for Microbiology lifetime achievement award

Allan M. Campbell, the Barbara Kimball Browning Professor in the School of Humanities and Sciences at Stanford University, will receive the 2004 Abbott-ASM Lifetime Achievement Award from the American Society for Microbiology at the society's 104th general meeting in New Orleans on Monday, May 24. Campbell will deliver the Abbott-ASM Award Lecture at 10:45 a.m. CDT and will be honored at a dinner ceremony that evening. The award includes a $20,000 cash prize and a commemorative piece.

In honoring Campbell, ASM officials cited his "exceptional insights and achievements in the field of molecular genetics - a career of groundbreaking research that has had a profound influence on several fields, including molecular cloning and gene therapy."

One of his most celebrated accomplishments, ASM officials noted, was demonstrating the genetic relationship between bacteriophage lambda - one of a group of viruses that attack bacteria - and its host. In the 1950s, Campbell concluded that bacteriophage lambda associates and dissociates from its host by inserting and removing a circular viral genome, or set of genes, into the bacterial chromosome. This finding, known as the Campbell model, paved the way for genetic and biochemical studies of site-specific recombination - the exchange of genetic information between the genomes of different species - as well as current research on the manipulation of genomes.

"These early studies led to other noted achievements, including Campbell's discovery of nonsense mutations and important work on bacterial gene regulation," ASM officials said. "His studies of microbial population dynamics and the evolution of genome structure have increased microbiologists' understanding of such questions as how viruses act as agents of evolution for host genomes and the interaction between bacteriophage evolution and population structure."

Campbell also is being recognized for his "extraordinary commitment" to
'"/>

Contact: Mark Shwartz
mshwartz@stanford.edu
650-723-9296
Stanford University
30-Apr-2004


Page: 1 2

Related biology news :

1. Campbell wins 2004 Abbott-ASM Lifetime Achievement Award
2. Edward C. Roy Jr. to receive Ian Campbell award
3. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
4. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
5. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
6. Martin Saunders to receive the James Flack Norris Award
7. Research on carbohydrate metabolism receives historical recognition
8. K-States National Agricultural Biosecurity Center receives $1.3 Million from Department of Defense
9. Berkeley Lab soil scientist Margaret Torn receives Presidential Early Career Award
10. NJIT professor receives Presidential Award for breakthrough research with adult stem cells
11. University of Pittsburgh receives $10 million grant for head and neck cancer

Post Your Comments:
(Date:5/21/2013)... types become most deadly when they metastasize and spread ... stage, it becomes very difficult for doctors to locate ... researchers at the University of Missouri have found a ... cells wherever they may be in the body. Michael ... College of Veterinary Medicine, says being able to target ...
(Date:5/21/2013)... available in pharmacies and health stores, phosphatidylserine is ... and soy. Proven to improve cognition and slow ... people experiencing memory impairment. Now a team headed ... of Tel Aviv University,s Department of Human ... supplement improves the functioning of genes involved in ...
(Date:5/21/2013)... Try staying fit in space, where living quarters are ... That,s the challenge a group of Michigan State University ... grant from NASA. Their goal is to keep astronauts ... could give astronauts the best exercise regimen there is, ... it, it isn,t going to help," said project leader ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2Common food supplement fights degenerative brain disorders 2Fueling fitness on the final frontier 2
(Date:5/21/2013)... 21, 2013 According to a ... http://www.transparencymarketresearch.com ) "Biochip Products and Services Market (Microarrays, Reagents, ... Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market ... is expected to grow at a CAGR of 10.1% ... of USD 4.7 billion in 2018. Browse ...
(Date:5/21/2013)... Miami, FL (PRWEB) May 21, 2013 ... and breakouts as contributor to acne. Recently physicians from ... effects of mental stress on the skin, and suggested ... to help reduce the chemicals produced from stress that ... aside from the negative feelings acne brings about, stress ...
(Date:5/21/2013)... May 21, 2013  MacroGenics, Inc. today announced ... margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody (MAb), ... HER2 oncoprotein," will be presented at the 2013 ... Oncology during the Developmental Therapeutics - Immunotherapy Oral ... – 4:30 PM.  The presentation will describe the ...
(Date:5/21/2013)... , May 21, 2013  Personal Genome ... use its proprietary methodologies and expertise in genomic ... kinase targets in collaboration with Blueprint Medicines.  PGDx ... at identifying genomic alterations in tumors, and Blueprint ... kinase inhibitors for a genetically defined patient population. ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3
Cached News: